Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Beam focal spot intrafraction motion and gantry angle dependence: A study of Varian linac focal spot alignment.

Slama LA, Riis HL, Sabet M, Barnes MP, Ebert MA, Chan S, Rowshanfarzad P.

Phys Med. 2019 Jul;63:41-47. doi: 10.1016/j.ejmp.2019.05.021. Epub 2019 May 29.

PMID:
31221407
2.

[Strongyloidiasis, a sexually transmitted disease].

Bourée P, Usubillaga R, Viard JP, Slama L, Salmon D.

Presse Med. 2019 Mar;48(3 Pt 1):322-324. doi: 10.1016/j.lpm.2019.02.028. Epub 2019 Mar 8. French. No abstract available.

PMID:
30853289
3.

Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship.

Penot P, Héma A, Bado G, Sombié D, Kaboré FN, Poda A, Michon C, Terzolo O, Traoré A, Slama L, Sawadogo A, Laurent C.

AIDS Care. 2018 Dec;30(12):1502-1506. doi: 10.1080/09540121.2018.1497132. Epub 2018 Jul 11.

PMID:
29991274
4.

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression.

Supervie V, Assoumou L, Breban R, Lert F, Costagliola D, Pialoux G, Landman R, Girard PM, Slama L; IMEA 040 DATA Study Group.

J Antimicrob Chemother. 2017 Nov 1;72(11):3172-3176. doi: 10.1093/jac/dkx276.

PMID:
28961977
5.

Necrotizing sialometaplasia of the parotid gland associated with facial nerve paralysis.

Haen P, Ben Slama L, Goudot P, Schouman T.

J Stomatol Oral Maxillofac Surg. 2017 Feb;118(1):63-65. doi: 10.1016/j.jormas.2016.11.001. Epub 2017 Feb 3.

PMID:
28330578
6.

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults.

Raffi F, Orkin C, Clarke A, Slama L, Gallant J, Daar E, Henry K, Santana-Bagur J, Stein DK, Bellos N, Scarsella A, Yan M, Abram ME, Cheng A, Rhee MS.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):226-231. doi: 10.1097/QAI.0000000000001344.

7.

Changes in bone turnover markers with HIV seroconversion and ART initiation.

Slama L, Reddy S, Phair J, Palella FJ Jr, Brown TT; Multicenter AIDS Cohort Study group (MACS).

J Antimicrob Chemother. 2017 May 1;72(5):1456-1461. doi: 10.1093/jac/dkx011.

8.

Bacterial chondritis complications following ear piercing.

Bellaud G, Canestri A, Gallah S, Merlant M, Cousseau S, Lebrette MG, Slama L, Pialoux G.

Med Mal Infect. 2017 Feb;47(1):26-31. doi: 10.1016/j.medmal.2016.07.002. Epub 2016 Sep 3.

PMID:
27596713
9.

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).

Slama L, Landman R, Assoumou L, Benalycherif A, Samri A, Joly V, Pialoux G, Valin N, Cabié A, Duvivier C, Lambert-Niclot S, Marcelin AG, Peytavin G, Costagliola D, Girard PM; IMEA 040 DATA Study Group.

J Antimicrob Chemother. 2016 Aug;71(8):2252-61. doi: 10.1093/jac/dkw103. Epub 2016 Apr 10.

PMID:
27068399
10.

Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men.

Slama L, Jacobson LP, Li X, Palella FJ Jr, Margolick JB, Kingsley LA, Wiley DJ, Pialoux G, Dobs AS, Brown TT; Multicenter AIDS Cohort Study.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):57-64. doi: 10.1097/QAI.0000000000000821.

11.

Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.

Launay O, Abitbol V, Krivine A, Slama LB, Bourreille A, Dupas JL, Hébuterne X, Savoye G, Deplanque D, Bouhnik Y, Pelletier AL, Galtier F, Laharie D, Nachury M, Zerbib F, Allez M, Bommelaer G, Duclos B, Lucht F, Gougeon ML, Tartour E, Rozenberg F, Hanslik T, Beaugerie L, Carrat F; MICIVAX Study Group.

J Crohns Colitis. 2015 Dec;9(12):1096-107. doi: 10.1093/ecco-jcc/jjv152. Epub 2015 Sep 7.

PMID:
26351392
12.

Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.

Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O; ANRS VIHVO Study Group.

Vaccine. 2015 Sep 11;33(38):4938-44. doi: 10.1016/j.vaccine.2015.07.036. Epub 2015 Jul 23.

PMID:
26209841
13.

The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso.

Chas J, Hema A, Slama L, Kabore NF, Lescure FX, Fontaine C, Pialoux G, Sawadogo A.

PLoS One. 2015 May 13;10(5):e0125588. doi: 10.1371/journal.pone.0125588. eCollection 2015.

14.

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.

Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C; OPTIPRIM ANRS Study Group.

Lancet Infect Dis. 2015 Apr;15(4):387-96. doi: 10.1016/S1473-3099(15)70021-6. Epub 2015 Feb 18.

PMID:
25701561
15.

Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010.

Geri G, Maynard M, Rosenthal E, Fontaine H, Lacombe K, Slama L, Goujard C, Loustaud-Ratti V, Bergmann JF, Morlat P, Vittecoq D, Alric L, Cacoub P; GERMIVIC Group.

Liver Int. 2014 Oct;34(9):1349-57.

PMID:
25368876
16.

Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters.

Slama L, Palella FJ Jr, Abraham AG, Li X, Vigouroux C, Pialoux G, Kingsley L, Lake JE, Brown TT.

J Antimicrob Chemother. 2014 Dec;69(12):3360-7. doi: 10.1093/jac/dku295. Epub 2014 Aug 4.

17.

The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.

Penot P, Héma A, Bado G, Kaboré F, Soré I, Sombié D, Traoré JR, Guiard-Schmid JB, Fontanet A, Slama L, Bruno Sawadogo A, Laurent C.

J Int AIDS Soc. 2014 Jan 15;17:18646. doi: 10.7448/IAS.17.1.18646. eCollection 2014.

18.

Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study.

Slama L, Li X, Brown T, Jacobson LP, Pialoux G, Macatangay B, Bolan RK, Phair J, Palella FJ Jr; Multicenter AIDS cohort Study.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):57-64. doi: 10.1097/QAI.0b013e3182a99a0d.

19.

[Fatty tumors of the jaws].

Ben Slama L, Landoulsi Helal A, Fodha Ben Jilani H, Zairi I, Adouani A.

Rev Stomatol Chir Maxillofac Chir Orale. 2014 Feb;115(1):42-4. doi: 10.1016/j.revsto.2013.09.001. Epub 2014 Jan 10. Review. French.

PMID:
24412402
20.

[Potentially malignant character of oral lichen planus and lichenoid lesions].

Mares S, Ben Slama L, Gruffaz F, Goudot P, Bertolus C.

Rev Stomatol Chir Maxillofac Chir Orale. 2013 Nov;114(5):293-8. doi: 10.1016/j.revsto.2013.05.007. Epub 2013 Jul 10. French.

PMID:
23849797
21.

Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso.

Bado G, Penot P, N'Diaye MD, Amiel C, Hema A, Kamboulé EB, Guiard-Schmid JB, Kaboré NF, Slama L, Bambara A, Laurent C, Sangaré L, Sawadogo AB.

Med Mal Infect. 2013 May;43(5):202-7. doi: 10.1016/j.medmal.2013.04.001. Epub 2013 May 20.

PMID:
23701923
22.

A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection.

Bacchus C, Cheret A, Avettand-Fenoël V, Nembot G, Mélard A, Blanc C, Lascoux-Combe C, Slama L, Allegre T, Allavena C, Yazdanpanah Y, Duvivier C, Katlama C, Goujard C, Seksik BC, Leplatois A, Molina JM, Meyer L, Autran B, Rouzioux C; OPTIPRIM ANRS 147 study group.

PLoS One. 2013 May 14;8(5):e64219. doi: 10.1371/journal.pone.0064219. Print 2013.

23.

Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.

Ghosn J, Slama L, Chermak A, Houssaini A, Lambert-Niclot S, Schneider L, Fourn E, Duvivier C, Simon A, Courbon E, Murphy R, Flandre P, Peytavin G, Katlama C; RADAR Study Group.

J Med Virol. 2013 Jan;85(1):8-15. doi: 10.1002/jmv.23404. Epub 2012 Sep 28.

PMID:
23024008
24.

[French Society of STomatology and Maxillo-facial Surgery: the mutation].

Ben Slama L.

Rev Stomatol Chir Maxillofac. 2012 Sep;113(4):203-4. doi: 10.1016/j.stomax.2012.07.007. French. No abstract available.

PMID:
22959280
25.

HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.

Vingert B, Benati D, Lambotte O, de Truchis P, Slama L, Jeannin P, Galperin M, Perez-Patrigeon S, Boufassa F, Kwok WW, Lemaître F, Delfraissy JF, Thèze J, Chakrabarti LA.

J Virol. 2012 Oct;86(19):10661-74. doi: 10.1128/JVI.00056-12. Epub 2012 Jul 25.

26.

Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 substudy.

Valantin MA, Kolta S, Flandre P, Algarte Genin M, Meynard JL, Ponscarme D, Slama L, Cuzin L, de Kerviler E, Inaoui R, Katlama C.

HIV Med. 2012 Sep;13(8):505-15. doi: 10.1111/j.1468-1293.2012.01004.x. Epub 2012 Mar 14.

27.

Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection.

Harfouch S, Guiguet M, Valantin MA, Samri A, Ouazene Z, Slama L, Dominguez S, Simon A, Theodorou I, Thibault V, Autran B; ANRS HC EP21 study group.

J Hepatol. 2012 Jun;56(6):1259-68. doi: 10.1016/j.jhep.2012.01.021. Epub 2012 Feb 9.

PMID:
22326469
28.

[The 48th congress of the French Society of Stomatology, Maxillo-Facial Surgery, from 26 to 29th of September 2012 at Versailles].

Ben Slama L.

Rev Stomatol Chir Maxillofac. 2012 Feb;113(1):1-2. doi: 10.1016/j.stomax.2012.01.002. French. No abstract available.

PMID:
22325827
29.

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.

Valantin MA, Lambert-Niclot S, Flandre P, Morand-Joubert L, Cabiè A, Meynard JL, Ponscarme D, Ajana F, Slama L, Curjol A, Cuzin L, Schneider L, Taburet AM, Marcelin AG, Katlama C; MONOI ANRS 136 Study Group.

J Antimicrob Chemother. 2012 Mar;67(3):691-5. doi: 10.1093/jac/dkr504. Epub 2011 Dec 7.

PMID:
22160145
30.

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.

Vrouenraets SM, Wit FW, Fernandez Garcia E, Moyle GJ, Jackson AG, Allavena C, Raffi F, Jayaweera DT, Mauss S, Katlama C, Fisher M, Slama L, Hardy WD, Dejesus E, van Eeden A, Reiss P; BASIC Study Group.

HIV Med. 2011 Nov;12(10):620-31. doi: 10.1111/j.1468-1293.2011.00941.x. Epub 2011 Aug 7.

31.

HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization.

Landires I, Bugault F, Lambotte O, de Truchis P, Slama L, Danckaert A, Delfraissy JF, Thèze J, Chakrabarti LA.

AIDS. 2011 Sep 24;25(15):1843-53. doi: 10.1097/QAD.0b013e32834a3678.

PMID:
21716071
32.

Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.

Micol R, Ben Slama L, Suarez F, Le Mignot L, Beauté J, Mahlaoui N, Dubois d'Enghien C, Laugé A, Hall J, Couturier J, Vallée L, Delobel B, Rivier F, Nguyen K, Billette de Villemeur T, Stephan JL, Bordigoni P, Bertrand Y, Aladjidi N, Pedespan JM, Thomas C, Pellier I, Koenig M, Hermine O, Picard C, Moshous D, Neven B, Lanternier F, Blanche S, Tardieu M, Debré M, Fischer A, Stoppa-Lyonnet D; CEREDIH Network Investigators.

J Allergy Clin Immunol. 2011 Aug;128(2):382-9.e1. doi: 10.1016/j.jaci.2011.03.052. Epub 2011 Jun 12.

PMID:
21665257
33.

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdière N, Slama L, Martin K, Lortholary O, Carrat F; ANRS HB03 VIHVAC-B Trial.

JAMA. 2011 Apr 13;305(14):1432-40. doi: 10.1001/jama.2011.351.

PMID:
21486976
34.

[Anti-inflammatory and repair activity of two toothpastes in an ex-vivo human gingival mucosa model].

Boisnic S, Ben Slama L, Branchet-Gumila MC.

Rev Stomatol Chir Maxillofac. 2010 Nov-Dec;111(5-6):291-5. doi: 10.1016/j.stomax.2010.10.011. Epub 2010 Nov 26. French.

PMID:
21111432
35.

[Potentially malignant disorders of the oral mucosa: terminology and classification].

Ben Slama L.

Rev Stomatol Chir Maxillofac. 2010 Sep;111(4):208-12. doi: 10.1016/j.stomax.2010.07.007. Epub 2010 Aug 23. French.

PMID:
20739038
36.

Factors predictive of virological failure on atazanavir in 310 HIV-infected patients.

Lescure FX, Poirier JM, Meynard JL, Guiard-Schmid JB, Zouai O, Bonnard P, Slama L, Amiel C, Girard PM, Pialoux G.

AIDS. 2010 Jun 19;24(10):1593-5. doi: 10.1097/QAD.0b013e32833a2403.

PMID:
20539093
37.

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.

Kosmider O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B, Hunault-Berger M, Slama B, Vey N, Lacombe C, Solary E, Birnbaum D, Bernard OA, Fontenay M.

Leukemia. 2010 May;24(5):1094-6. doi: 10.1038/leu.2010.52. Epub 2010 Apr 8. No abstract available.

PMID:
20376084
38.

[Anti-inflammatory effect of enoxolone in an ex-vivo human gingival mucosa model].

Boisnic S, Ben Slama L, Branchet-Gumila MC, Watts M, d'Arros G.

Rev Stomatol Chir Maxillofac. 2010 Apr;111(2):69-73. doi: 10.1016/j.stomax.2010.02.005. Epub 2010 Mar 24. French.

PMID:
20338604
39.

Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen.

Chakvetadze C, Bani-Sadr F, Le Pendeven C, Lescure FX, Fontaine C, Galperine T, Slama L, Bonnard P, Mariot P, Soussan P, Pialoux G.

Clin Infect Dis. 2010 Apr 15;50(8):1184-6. doi: 10.1086/651422.

PMID:
20210647
40.

Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.

Antuna-Puente B, Boutet E, Vigouroux C, Lascols O, Slama L, Caron-Debarle M, Khallouf E, Lévy-Marchal C, Capeau J, Bastard JP, Magré J.

J Clin Endocrinol Metab. 2010 Mar;95(3):1463-8. doi: 10.1210/jc.2009-1824. Epub 2010 Jan 22.

PMID:
20097706
41.

Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients.

Valantin MA, Bittar R, de Truchis P, Bollens D, Slama L, Giral P, Bonnefont-Rousselot D, Pétour P, Aubron-Olivier C, Costagliola D, Katlama C; TOTEM trial group.

J Antimicrob Chemother. 2010 Mar;65(3):556-61. doi: 10.1093/jac/dkp462. Epub 2010 Jan 6.

PMID:
20053692
42.

[Bobo Dioulasso Teaching Hospital day-care hospital: a reference structure for the management of HIV infected patients in Burkina Faso].

Fontaine C, Hema A, Kamboule E, Guiard-Schmid JB, Lescure FX, Slama L, Pialoux G, Sawadogo A.

Med Mal Infect. 2010 Jul;40(7):393-7. doi: 10.1016/j.medmal.2009.10.018. Epub 2009 Nov 29. French.

PMID:
19951831
43.

Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial.

Meynard JL, Morand-Joubert L, Lacombe K, Poirier JM, Slama L, Valantin MA, Girard PM.

J Antimicrob Chemother. 2010 Jan;65(1):125-8. doi: 10.1093/jac/dkp396.

PMID:
19919951
44.

[Jaw muscle tumors].

Ben Slama L, Zaghbani A, Hidaya S.

Rev Stomatol Chir Maxillofac. 2009 Dec;110(6):335-7. doi: 10.1016/j.stomax.2009.07.005. Epub 2009 Oct 15. Review. French. Erratum in: Rev Stomatol Chir Maxillofac. 2010 Apr;111(2):119. Zoghbani, A [corrected to Zaghbani, A].

PMID:
19836039
45.

[Desmoplastic fibroma].

Ben Slama L, Zaghbani A, Hidaya S, Ruhin B.

Rev Stomatol Chir Maxillofac. 2009 Dec;110(6):327-8. doi: 10.1016/j.stomax.2009.07.007. Epub 2009 Oct 13. Review. French. Erratum in: Rev Stomatol Chir Maxillofac. 2010 Apr;111(2):119. Zoghbani, A [corrected to Zaghbani, A].

PMID:
19828163
46.

[Nasopalatine duct cyst].

Ben Slama L, Zoghbani A, Hidaya S.

Rev Stomatol Chir Maxillofac. 2009 Nov;110(5):284-6. doi: 10.1016/j.stomax.2009.07.006. Epub 2009 Oct 13. Review. French.

PMID:
19828162
47.

[Langerhans cell histiocytosis].

Ben Slama L, Ruhin B, Zoghbani A.

Rev Stomatol Chir Maxillofac. 2009 Nov;110(5):287-9. doi: 10.1016/j.stomax.2009.07.008. Epub 2009 Oct 13. Review. French.

PMID:
19828161
48.

[Nasolabial cyst].

Ben Slama L, Zaghbani A, Hidaya S.

Rev Stomatol Chir Maxillofac. 2009 Dec;110(6):338-9. doi: 10.1016/j.stomax.2009.09.004. Epub 2009 Oct 2. Review. French. Erratum in: Rev Stomatol Chir Maxillofac. 2010 Apr;111(2):119. Zoghbani, A [corrected to Zaghbani, A].

PMID:
19800645
49.

Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.

Schnuriger A, Dominguez S, Guiguet M, Harfouch S, Samri A, Ouazene Z, Slama L, Simon A, Valantin MA, Thibault V, Autran B; ANRS HC EP21 study group.

AIDS. 2009 Oct 23;23(16):2079-89. doi: 10.1097/QAD.0b013e328330ed24.

PMID:
19710595
50.

[Carcinoma of the lips].

Ben Slama L.

Rev Stomatol Chir Maxillofac. 2009 Nov;110(5):278-83. doi: 10.1016/j.stomax.2009.03.001. Epub 2009 Apr 9. Review. French.

PMID:
19361830

Supplemental Content

Support Center